CEA, AFP and other potential tumor markers.

Suppr

超能文献

作者信息

Zamcheck N, Pusztaszeri G

出版信息

CA Cancer J Clin. 1975 Jul-Aug;25(4):204-14. doi: 10.3322/canjclin.25.4.204.

DOI:10.3322/canjclin.25.4.204

PMID:48409

Abstract

摘要

相似文献

CEA, AFP and other potential tumor markers.

CA Cancer J Clin. 1975 Jul-Aug;25(4):204-14. doi: 10.3322/canjclin.25.4.204.

CEA and tumor markers.

Semin Oncol. 1976 Dec;3(4):377-85.

Simultaneous radioimmunoassay for carcinoembryonic antigen (CEA) and alpha-fetoprotein (alphaFP) in neoplasms of the gastro-intestinal tract.胃肠道肿瘤中癌胚抗原（CEA）和甲胎蛋白（αFP）的同步放射免疫测定

Ann Clin Lab Sci. 1974 Mar-Apr;4(2):104-8.

Radioimmunoassay for gamma-a fetal protein in serum of patients with cancer and nonmalignant diseases.

Surg Forum. 1974;25(0):126-7.

[CEA, AFP, CPALP (Nagao) in a male patient with gastric carcinoma metastatic to the liver (author's transl)].一名胃癌肝转移男性患者的癌胚抗原、甲胎蛋白、CPALP（长尾法）（作者译）

Nihon Shokakibyo Gakkai Zasshi. 1975 Nov;72(11):1407-12.

Immunologic tests for the detection of gastrointestinal cancers: status report on carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP).

South Med J. 1973 Nov;66(11):1218-21. doi: 10.1097/00007611-197311000-00003.

Current status of carcinoembryonic antigen assay.癌胚抗原检测的现状

Semin Nucl Med. 1975 Jul;5(3):255-62. doi: 10.1016/s0001-2998(75)80013-4.

Simultaneous assays of cancer-associated antigens in various neoplastic disorders.多种肿瘤性疾病中癌症相关抗原的同步检测。

Cancer. 1976 Dec;38(6):2287-95. doi: 10.1002/1097-0142(197612)38:6<2287::aid-cncr2820380616>3.0.co;2-2.

Carcinoembryonic antigen (CEA) in non digestive cancerous and normal tissues.非消化系统癌组织和正常组织中的癌胚抗原（CEA）

Immunochemistry. 1973 Mar;10(3):197-204. doi: 10.1016/0019-2791(73)90008-6.

A collaborative clinical study of carcinoembryonic antigen in Japan.日本癌胚抗原的一项合作临床研究。

Cancer Res. 1977 Jul;37(7 Pt 1):2267-74.

引用本文的文献

Circulating tumor DNA methylation markers for the early diagnosis of hepatocellular carcinoma.用于肝细胞癌早期诊断的循环肿瘤DNA甲基化标志物

Clin Exp Med. 2025 Mar 14;25(1):83. doi: 10.1007/s10238-025-01599-x.

Targeted Biodegradable Near-Infrared Fluorescent Nanoparticles for Colorectal Cancer Imaging.用于结直肠癌成像的靶向可生物降解近红外荧光纳米颗粒

ACS Appl Bio Mater. 2024 Dec 16;7(12):7861-7870. doi: 10.1021/acsabm.4c00072. Epub 2024 Apr 4.

Long non-coding RNA CASC7 is a promising serum biomarker for hepatocellular carcinoma.长链非编码 RNA CASC7 是一种有前途的肝细胞癌血清标志物。

BMC Gastroenterol. 2023 Sep 21;23(1):324. doi: 10.1186/s12876-023-02961-7.

Clinical utility and diagnostic value of tumor-educated platelets in lung cancer: a systematic review and meta-analysis.肿瘤诱导血小板在肺癌中的临床应用及诊断价值：一项系统评价与Meta分析

Front Oncol. 2023 Jul 26;13:1201713. doi: 10.3389/fonc.2023.1201713. eCollection 2023.

Analysis of patients with colorectal cancer shows a specific increase in serum anti-ING1 autoantibody levels.对结直肠癌患者的分析显示，血清抗 ING1 自身抗体水平特异性升高。

BMC Cancer. 2023 Apr 18;23(1):356. doi: 10.1186/s12885-023-10845-y.

Extracellular Vesicles and Circulating Tumour Cells - complementary liquid biopsies or standalone concepts?细胞外囊泡和循环肿瘤细胞——互补的液体活检还是独立的概念？

Theranostics. 2022 Aug 1;12(13):5836-5855. doi: 10.7150/thno.73400. eCollection 2022.

Clinical Applications of Liquid Biopsy in Hepatocellular Carcinoma.液体活检在肝细胞癌中的临床应用

Front Oncol. 2022 Feb 8;12:781820. doi: 10.3389/fonc.2022.781820. eCollection 2022.

Hallmark microRNA signature in liquid biopsy identifies hepatocellular carcinoma and differentiates it from liver metastasis.液体活检中的标志性微小RNA特征可识别肝细胞癌并将其与肝转移瘤区分开来。

J Cancer. 2021 Jun 1;12(15):4585-4594. doi: 10.7150/jca.59933. eCollection 2021.

RRM2 protects against ferroptosis and is a tumor biomarker for liver cancer.核糖核苷酸还原酶M2亚基可抵御铁死亡，是肝癌的一种肿瘤生物标志物。

Cancer Cell Int. 2020 Dec 7;20(1):587. doi: 10.1186/s12935-020-01689-8.

Liquid Biopsies in Hepatocellular Carcinoma: Are We Winning?肝细胞癌的液体活检：我们成功了吗？

J Clin Med. 2020 May 20;9(5):1541. doi: 10.3390/jcm9051541.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验